Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Irritable Bowel Syndrome (IBS) Health Center

Font Size

More Upsetting News About Irritable Bowel Treatment

By Ori Twersky
WebMD Health News

Oct. 31, 2000 (Washington) -- Following 49 reports of a serious bowel condition called ischemic colitis and five reported deaths among people taking Lotronex, a drug for irritable bowel syndrome (IBS), U.S. health officials are re-evaluating the risks and benefits of the drug. Though the FDA has yet to review the reports, and though a link with Lotronex has not been established, enough concern has been raised to warrant further investigation.

FDA officials confirmed Monday that they are re-evaluating Lotronex after the prominent consumer watchdog group Public Citizen released a letter urging FDA Commissioner Jane Henney, MD, to withdraw the IBS drug from the U.S. market. In the letter, the group said that the drug was linked to 54 cases of ischemic colitis, making it "irresponsible for Glaxo Wellcome and for the FDA to allow this doomed drug to stay on the market any longer."

IBS is a disorder of the large intestine that is characterized by abdominal pain and either constipation or diarrhea. It affects mostly women and occurs in about 15% of Americans, or five out of every 1,000 people. Ischemic colitis is a potentially life-threatening inflammation of the large intestine that is caused when blood flow to that area of the gastrointestinal tract is blocked.

Lotronex, made by the U.K.'s Glaxo Wellcome, blocks certain receptors for serotonin, a chemical that relays sensations from the body to the brain. The blocked receptors, which are found throughout the gastrointestinal tract, are thought to play a large role in relaying the sensation of pain from the intestines to the brain. The receptors also are believed to help regulate certain bowel functions.

This is not the first time the FDA has investigated a link between Lotronex and ischemic colitis, or that Public Citizen has called for the drug to be withdrawn. In late June, an expert panel of the FDA reviewed the link and concluded that a stricter warning label might be warranted -- even though the rate or cause of ischemic colitis was not fully understood. Then in August, Public Citizen called for the drug's withdrawal, citing the FDA's own publicly declared concerns as the basis of its complaint.

1 | 2 | 3 | 4

Today on WebMD

filling glass of water from faucet
Prevention strategies to try.
stomach ache
From symptoms to treatments.
Causes, symptoms, and treatments.
worried mature woman
Are they related?
IBS Trigger Foods
Supplements for IBS What Works
IBS Symptoms Quiz
digestive health
gluten free diet
digestive myths
what causes diarrhea
man with abdominal pain

WebMD Special Sections